ENTITY
Indegene

Indegene (INDGN IN)

37
Analysis
Health Care • India
Indegene Limited operates as a life sciences commercialization company. The Company offers enterprise commercial, medical transformation, data and analysis, products development, and omni-channel activation solutions. Indegene serves customers worldwide.
more
bullish•Reliance Industries
•11 Jan 2024 10:55

Aequitas 2024 Asia IPO Pipeline - India

In this note, we will take a look at the Asia Pacific IPO pipeline for 2024, following up with India after having looked at Hong Kong earlier.

Logo
660 Views
Share
bullish•Tencent
•01 May 2023 09:10

ECM Weekly (1st May 2023) - ZJLD, Mankind, JD Industrial, JD Property, CPF Global Food, Horizon

Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.

Logo
522 Views
Share
bullish•Rakuten Bank
•23 Apr 2023 07:25

ECM Weekly (23rd Apr 2023) - Rakuten Bank, Merdeka, ZJLD, Mankind, Lalatech, IMotion, Anta, KIT

Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.

Logo
536 Views
Share
bullish•Indegene
•19 Apr 2023 10:51

Indegene Pre-IPO - Growing Client Base and Cross/Up-Selling Led to Growth

Indegene Limited (1864095D IN) is looking to raise about US$400m in its upcoming India IPO. Indegene is a “digital-first” commercialisation firm...

Logo
644 Views
Share
bullish•Indegene
•13 Apr 2023 19:48

Indegene Limited (1864095D IN) Pre-IPO: Enough Head Room For Long-Term Profitable Growth

Indegene, a healthtech company, plans to raise INR32B via IPO to repay debt, fund capex, and pursue acquisitions. Amid secular industry tailwind,...

Logo
651 Views
Share
x